LEXARIA BIOSCIENCE CORP. Construction in Progress, Gross
LEXARIA BIOSCIENCE CORP. (LEXX) had Construction in Progress, Gross of $79.49 thousand as of 2018-11-30, per its 10-Q filed 2019-01-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:ConstructionInProgressGross · last filed 2019-01-11
- 2018-11-30: Construction in Progress, Gross $79.49K.
- 2018-08-31: Construction in Progress, Gross $0.00.
| Period end | Construction in Progress, Gross |
|---|---|
| 2018-11-30 | $79.49K 10-Q · filed 2019-01-11 |
| 2018-08-31 | $0.00 10-Q · filed 2019-01-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |